Pulmonary Crohn's disease: A rare extra-intestinal manifestation treated with infliximab

Journal of Crohn's and Colitis

Volumn 3, Issue 3, 2009, Pages 207-211

  Pedersen, Natalia ^a   Duricova, Dana ^b   Munkholm, Pia ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Crohn's disease; Infliximab; Pulmonary extra intestinal manifestation

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CORTICOSTEROID; INFLIXIMAB; MESALAZINE;

ADULT; ARTICLE; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CASE REPORT; CLINICAL FEATURE; COLITIS; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; LUNG CROHN DISEASE; LUNG INFILTRATE; PRIORITY JOURNAL; RELAPSE; REMISSION; TREATMENT OUTCOME;

EID: 67651111854     PISSN: 18739946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crohns.2009.03.007     Document Type: Article

References (28)

1. Juillerat P., Mottet C., Froehlich F., Felley C., Vader J.P., Burnand B., et al. Extraintestinal manifestations of Crohn's disease. Digestion 71 (2005) 31-36
2. Camus P., and Colby T.V. The lung in inflammatory bowel disease. Eur Respir J 15 (2000) 5-10
3. Storch I., Sachar D., and Katz S. Pulmonary manifestations of inflammatory bowel disease. Inflamm Bowel Dis 9 (2003) 104-115
4. Barrie A., and Plevy S. Treatment of immune-mediated extraintestinal manifestations of inflammatory bowel disease with infliximab. Gastroenterol Clin North Am 35 (2006) 883-893
5. Barrie A., and Regueiro M. Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis 13 (2007) 1424-1429
6. Kaufman I., Caspi D., Yeshurun D., Dotan I., Yaron M., and Elkayam O. The effect of infliximab on extraintestinal manifestations of Crohn's disease. Rheumatol Int 25 (2005) 406-410
7. Siemanowski B., and Regueiro M. Efficacy of infliximab for extraintestinal manifestations of inflammatory bowel disease. Curr Treat Options Gastroenterol 10 (2007) 178-184
8. Alrashid A.I., Brown R.D., Mihalov M.L., Sekosan M., Pastika B.J., and Venu R.P. Crohn's disease involving the lung: resolution with infliximab. Dig Dis Sci 46 (2001) 1736-1739
9. Casey M.B., Tazelaar H.D., Myers J.L., Hunninghake G.W., Kakar S., Kalra S.X., et al. Noninfectious lung pathology in patients with Crohn's disease. Am J Surg Pathol 27 (2003) 213-219
10. Gill K.R., and Mahadevan U. Infliximab for the treatment of metastatic hepatic and pulmonary Crohn's disease. Inflamm Bowel Dis 11 (2005) 210-212
11. Krishnan S., Banquet A., Newman L., Katta U., Patil A., and Dozor A.J. Lung lesions in children with Crohn's disease presenting as nonresolving pneumonias and response to infliximab therapy. Pediatrics 117 (2006) 1440-1443
12. Bartholo R.M., Zaltman C., Elia C., Cardoso A.P., Flores V., Lago P., et al. Bronchial hyperresponsiveness and analysis of induced sputum cells in Crohn's disease. Braz J Med Biol Res 38 (2005) 197-203
13. Herrlinger K.R., Noftz M.K., Dalhoff K., Ludwig D., Stange E.F., and Fellermann K. Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission. Am J Gastroenterol 97 (2002) 377-381
14. Munck A., Murciano D., Pariente R., Cezard J.P., and Navarro J. Latent pulmonary function abnormalities in children with Crohn's disease. Eur Respir J 8 (1995) 377-380
15. Neilly J.B., Main A.N., McSharry C., Murray J., Russell R.I., and Moran F. Pulmonary abnormalities in Crohn's disease. Respir Med 83 (1989) 487-491
16. Schleiermacher D., and Hoffmann J.C. Pulmonary abnormalities in inflammatory bowel disease. Journal of Crohn's and Colitis 1 (2007) 61-69
17. Bouchardy L.M., Kuhlman J.E., Ball Jr. W.C., Hruban R.H., Askin F.B., and Siegelman S.S. CT findings in bronchiolitis obliterans organizing pneumonia (BOOP) with radiographic, clinical, and histologic correlation. J Comput Assist Tomogr 17 (1993) 352-357
18. Carratu P., Dragonieri S., Nocerino M.C., Trabucco S.M., Lacedonia D., Parisi G., et al. A case of cryptogenic organizing pneumonia occurring in Crohn's disease. Can Respir J 12 (2005) 437-439
19. Mahadeva R., Walsh G., Flower C.D., and Shneerson J.M. Clinical and radiological characteristics of lung disease in inflammatory bowel disease. Eur Respir J 15 (2000) 41-48
20. Kraft S.C., Earle R.H., Roesler M., and Esterly J.R. Unexplained bronchopulmonary disease with inflammatory bowel disease. Arch Intern Med 136 (1976) 454-459
21. Lohr R.H., Boland B.J., Douglas W.W., Dockrell D.H., Colby T.V., Swensen S.J., et al. Organizing pneumonia. Features and prognosis of cryptogenic, secondary, and focal variants. Arch Intern Med 157 (1997) 1323-1329
22. Oymak F.S., Demirbas H.M., Mavili E., Akgun H., Gulmez I., Demir R., et al. Bronchiolitis obliterans organizing pneumonia. Clinical and roentgenological features in 26 cases. Respiration 72 (2005) 254-262
23. Weatherhead M., Masson S., Bourke S.J., Gunn M.C., and Burns G.P. Interstitial pneumonitis after infliximab therapy for Crohn's disease. Inflamm Bowel Dis 12 (2006) 427-428
24. Omori H., Asahi H., Inoue Y., Irinoda T., and Saito K. Pulmonary involvement in Crohn's disease report of a case and review of the literature. Inflamm Bowel Dis 10 (2004) 129-134
25. Basarakodu K.R., Aronow W.S., Nair C.K., Lakkireddy D., Kondur A., Korlakunta H., et al. Differences in treatment and in outcomes between idiopathic and secondary forms of organizing pneumonia. Am J Ther 14 (2007) 422-426
26. Hanauer S.B., Feagan B.G., Lichtenstein G.R., Mayer L.F., Schreiber S., Colombel J.F., et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 359 (2002) 1541-1549
27. Sands B.E., Anderson F.H., Bernstein C.N., Chey W.Y., Feagan B.G., Fedorak R.N., et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 350 (2004) 876-885
28. Silbermintz A., Krishnan S., Banquet A., and Markowitz J. Granulomatous pneumonitis, sclerosing cholangitis, and pancreatitis in a child with Crohn disease: response to infliximab. J Pediatr Gastroenterol Nutr 42 (2006) 324-326